Today: 21 March 2026
Subscribe
Browse Category

IPO News 13 December 2025 - 27 December 2025

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining Corporation Stock (NYSE: B, TSX: ABX) in Focus as Gold Breaks $4,400: Mali Restart, IPO Review, and 2026 Outlook (22.12.2025)

Barrick Mining shares are trading near the mid-$40s after gold hit a record $4,420 per ounce, up two-thirds in 2025. The easing of geopolitical risks in Mali and a strategic overhaul are also driving the stock. Barrick’s 12-month range swung from the mid-teens to mid-$40s. Wall Street forecasts gold could reach $4,900/oz by late 2026.
22 December 2025
···
Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho Share Price Today (Dec 22, 2025): Why NSE: MEESHO Stock Slipped After a 2x IPO Rally — and What Analysts Forecast Next

Meesho shares fell about 6–7% to near ₹209–₹212 by midday Monday, December 22, after a sharp post-IPO rally that briefly pushed its market cap above ₹1 trillion. The stock has dropped roughly 8% over two sessions, reversing gains that saw it more than double from its ₹111 issue price after debuting on December 10. Traders cite profit-taking and limited supply as factors behind the volatility.
22 December 2025
··
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

India’s NSE ended the week with the India VIX volatility index at a record low of 9.71 on December 18, signaling unusually calm equity markets despite record derivatives activity. Analysts say tighter regulations and strong domestic flows have curbed short-term speculation. The exchange’s IPO remains delayed amid ongoing governance issues. Option traders face shrinking premiums and fewer intraday opportunities.
21 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

BioMarin agreed to acquire Amicus Therapeutics for $4.8 billion on Dec. 19, paying a 33% premium and adding two rare-disease drugs with $599 million in combined annual sales. The deal, plus an FDA approval for Cytokinetics and new IPO filings, drove biotech stocks higher ahead of the Christmas-shortened trading week. U.S. markets will close early Dec. 24 and remain shut Dec. 25.
21 December 2025
·····
Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

Shanghai Stock Exchange Update (Dec. 21, 2025): Shanghai Composite Near 3,900 as Policy Watch Meets STAR Market AI-IPO Boom

The Shanghai Composite Index closed Friday up 0.36% at 3,890.45, ending the week flat amid subdued trading and an earnings lull. November data showed industrial output growth slowed to 4.8% and retail sales rose just 1.3%, the weakest since late 2022. Property investment fell 15.9% year-to-date. The World Bank forecasts China’s 2025 growth at 4.9%, with further cooling expected in 2026.
21 December 2025
·
Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries Share Price Today: Why RIL Stock Is in Focus on Dec 21, 2025 as Brokerages Lift Targets and Jio IPO Buzz Builds

Reliance Industries shares closed at ₹1,565.10 on December 19, about 1% below their 52-week high, after rising 28% year-to-date. Market cap stands near ₹21.18 lakh crore. Morgan Stanley raised its target to ₹1,847, citing strong refining margins and new monetisation prospects. S&P Global upgraded Reliance’s credit profile, and Reuters reported progress toward a Jio IPO.
21 December 2025
····
Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley Stock (MS) Rallies on SpaceX IPO Buzz as Wall Street Eyes January Earnings and Fresh Forecasts

Morgan Stanley shares rose about 2.3% to $176.87 Friday, rebounding from a recent slide. The move followed a Reuters report naming the bank as a leading contender to manage a possible SpaceX IPO. Investors also focused on upbeat 2026 dealmaking forecasts and anticipation of Morgan Stanley’s fourth-quarter results in January. Intraday trading ranged from $173.07 to $177.54.
19 December 2025
···
Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan (NAVN) Stock News Today: Insider Buying Sparks a Bounce After Post‑IPO Slide, Earnings Whiplash, and Fresh Wall Street Forecasts

Navan shares jumped 11% to $15.27 by late morning Friday after director Anré D. Williams disclosed buying 100,000 shares in the open market at an average price of $12.72. The insider purchase, revealed in an SEC filing, followed a steep post-earnings selloff earlier in the week. Navan stock remains about 39% below its $25 IPO price.
19 December 2025
···
Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Stock (MDLN) After the Bell: IPO Closes, Shares Ease to $39.49 — What to Know Before Market Open Dec. 19, 2025

Medline Inc. closed its upsized IPO on Dec. 18, selling 248.4 million shares at $29 each, including the full underwriters’ option, raising about $7.2 billion. Shares ended regular trading at $39.98, down 2.49%, and traded near $39.49 after hours. The stock remains well above its IPO price after debuting at $41 on Wednesday. Proceeds will be used to repay debt and buy out pre-IPO owners.
18 December 2025
··
Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality IPO: Price Band Set at ₹108–₹114 for ₹251 Crore Issue; Key Dates, GMP Status, and Expansion Roadmap

Gujarat Kidney and Super Speciality Ltd has set its IPO price band at ₹108–₹114 per share for a ₹251 crore fresh issue opening December 22 and closing December 24, 2025. The minimum retail application is 128 shares, or ₹14,592 at the top end. Shares are expected to list on BSE and NSE December 30. The company will use proceeds mainly for acquisitions and expansion.
18 December 2025
·
Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

Nasdaq Stock Market Today (Dec. 17, 2025): Nasdaq Composite Slides 1.81% on AI Funding Jitters; Medline IPO Pops, Micron Jumps After Hours

The Nasdaq Composite dropped 418.14 points, or 1.81%, to 22,693.32 on Wednesday, its lowest close in three weeks, as concerns over AI infrastructure spending hit tech and chip stocks. Oracle fell 5.4% after Blue Owl Capital reportedly withdrew from a $10 billion Michigan data center project. Decliners outnumbered advancers more than 2-to-1. Nvidia and Broadcom lost 3.8% and 4.5%, respectively.
17 December 2025
····
Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc confirmed the underwriting agreement and final prospectus filing for the ICICI Prudential Asset Management IPO, with gross proceeds of about INR 106.03 billion expected. The company repurchased 773,817 shares for cancellation on 16 December. Shares hit a new 52-week high of 1,132p intraday on 17 December in London trading.
17 December 2025
···
Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho Limited Stock Jumps to Upper Circuit on Dec 17, 2025: UBS “Buy” Call, ₹220 Target, and What’s Next for Meesho Shares After the IPO

Meesho shares jumped 20% to a record high near ₹216 on December 17, 2025, after UBS initiated coverage with a “Buy” rating and a ₹220 target. Trading volume surged, with the stock nearly doubling its ₹111 IPO price within a week of listing. Market capitalization estimates ranged from ₹94,000 to ₹98,000 crore by late morning.
17 December 2025
···
Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Reliance Industries Share Price Today (16 December 2025): RIL Stock in Focus on AI Unit Launch, Jio IPO Signals; Analyst Targets Cluster Around ₹1,700+

Reliance Industries shares traded near ₹1,544 on Tuesday, down about 0.7% intraday, as markets slipped amid a weaker rupee and foreign outflows. The company began operations at its new AI subsidiary, Reliance Intelligence, led by Gaurav Aggarwal, with plans for data center expansion in Jamnagar.
16 December 2025
···
ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank stock today (15 Dec 2025): ICICIBANK holds near ₹1,366 as ICICI Prudential AMC IPO draws strong demand; what analysts forecast next

ICICI Bank shares traded near ₹1,366 on December 15, 2025, as Indian markets faced foreign outflows and a record-low rupee. The fully subscribed $1.2 billion IPO of ICICI Prudential AMC, where ICICI Bank holds a majority stake, drew strong demand. ICICI Bank ADR last traded at $30.24 in the U.S. Investors watched for updates from a Citi-hosted event scheduled for the day.
15 December 2025
··
Wakefit IPO Listing Today: Wakefit Innovations Shares Debut Flat at ₹195 on NSE, Slip Over 4% Soon After — What Investors Should Do

Wakefit IPO Listing Today: Wakefit Innovations Shares Debut Flat at ₹195 on NSE, Slip Over 4% Soon After — What Investors Should Do

Wakefit Innovations listed at ₹195 on the NSE and ₹194.10 on the BSE on December 15, 2025, matching or slightly below its IPO price. Shares fell over 4% in early trading, touching ₹183.61. The ₹1,288.89 crore IPO was subscribed 2.52 times, with retail and QIB demand outpacing NII. Grey market premiums had signaled a flat debut.
15 December 2025
···
Hong Kong Stock Market Week Ahead: HKEX Hang Seng Outlook After Fed Cut, China Data and IPO Momentum (Updated Dec 14, 2025)

Hong Kong Stock Market Week Ahead: HKEX Hang Seng Outlook After Fed Cut, China Data and IPO Momentum (Updated Dec 14, 2025)

The Hang Seng Index jumped 1.8% Friday to close at 25,976.79, trimming its weekly loss to 0.4% as traders anticipated new pro-growth signals from Beijing. Earlier in the week, rate uncertainty and mixed China data drove volatile trading, with property and tech shares under pressure. Investors are watching for key China data and Hong Kong’s response to lower rates in the coming days.
14 December 2025
···
Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) Stock Surges on SpaceX IPO Buzz: What Happened This Week, Premium-to-NAV Reality Check, and Week-Ahead Watchlist (Updated Dec. 12, 2025)

Destiny Tech100 (DXYZ) surged 38% in five sessions, closing Dec. 12 at $37.96 on heavy volume, as speculation over a potential SpaceX IPO drew investor interest. The closed-end fund, which holds late-stage private tech firms, traded far above its net asset value. Friday’s volume hit 7.58 million shares, with pre-market activity also spiking. DXYZ’s price often moves on sentiment rather than underlying portfolio value.
14 December 2025
··
Reliance Industries Share Price Today (13 Dec 2025): RIL Stock Near 52-Week High as Jio IPO Buzz, Retail IPO Roadmap and Media Clarity Shape Outlook

Reliance Industries Share Price Today (13 Dec 2025): RIL Stock Near 52-Week High as Jio IPO Buzz, Retail IPO Roadmap and Media Clarity Shape Outlook

Reliance Industries shares closed at ₹1,556.50 on Friday, near their 52-week high of ₹1,581.30. The ICC and JioStar denied reports of a media-rights exit, confirming their agreement remains active. JioHotstar announced a $444 million investment in South Indian content over five years. Market cap stands near ₹21.06 lakh crore.
13 December 2025
····
1 2 3 4 5 6

Stock Market Today

  • Is Disney Stock Fairly Valued Amid Recent Price Weakness?
    March 21, 2026, 1:51 AM EDT. Disney (DIS) shares have recently weakened, closing at $99.51 with a 7.1% drop over 30 days and 11% year-to-date decline. Over five years, the stock is down 45.2%. Despite mixed performance, Disney's valuation scores 5 out of 6 on Simply Wall St's metrics. A Discounted Cash Flow (DCF) model estimates Disney's intrinsic value at $99.89, nearly matching its current price, suggesting the stock is fairly valued with a slight 0.4% undervaluation. The DCF uses projected free cash flows rising to $14.10 billion by 2030, emphasizing Disney's long-term cash generation prospects. Investors should monitor Disney's valuation as cash flow estimates and market conditions evolve. The P/E ratio and other traditional metrics also provide context for assessing Disney's price relative to earnings and growth expectations.
Go toTop